News Archive
« Back to 2024
Research, Psychology, Science
–
Thursday, November 7, 2024
The psychologists and co‑directors at Ä¢¹½AV's Centre for Psychological Health share their personal journeys and research interests in the latest episode of Sciographies.
Sports, Community & Culture
–
Thursday, November 7, 2024
Players and Coach Tye share their excitement about this year’s championship hosted at Ä¢¹½AV for just the second time in program history.
Computer Science, Research, News
–
Thursday, November 7, 2024
The fellowship recognizes the computer scientist's groundbreaking work in personalized and adaptive digital interventions powered by artificial intelligence and machine learning and is accompanied by a research grant of $250,000 over the next two years.
Research, Biology, Science, Chemistry
–
Tuesday, November 5, 2024
Dina Rogers takes centre stage in Berlin this week along with close to 100 competitors from around the globe presenting their research-based ideas to improve the world to an audience of international thought leaders and Nobel Prize Laureates.
Research, News
–
Tuesday, November 5, 2024
Scenario planning provides an effective way for Canadian officials to address high levels of uncertainty in the Canada-U.S. relationship. Here’s how it works.
News, Senior Administration, Community & Culture
–
Monday, November 4, 2024
The evolution to People and Culture underscores Dal's commitment to nurturing belonging and fostering partnerships across units to provide a more holistic approach centered around the employee experience.
News, Community & Culture
–
Monday, November 4, 2024
The Honourable Murray Sinclair — lawyer, former senator, and chief commissioner of the Truth and Reconciliation Commission of Canada — passed away this week at the age of 73. Back in 2018, the Dal honorary degree recipient shared his vision of belonging as part of the university 200th anniversary celebrations.
Medicine, Research
–
Friday, November 1, 2024
The field of exercise oncology has been growing rapidly, showing benefits including reduced disease and treatment-related side effects like depression, anxiety, muscle weakness and cancer-related pain, as well as a reduced risk of disease recurrence and cancer mortality.